Guidant Defibrillator
|
In 2005 the Guidant Corporation recalled nearly 50,000 of its cardiac defibrillators implanted in patients worldwide because of defects that could lead to one's serious injury and death. It is believed that 38,000 defibrillators have been implanted in patients in the U.S. with another 12,000 around the world. The defective Guidant models that affected by the recall are the following: Prizm 2 DR; the Contak Renewal; Contak Renewal #2; the Ventak Prizm AVT; Vitality AVT; Renewal 3 AVT; and the Renewal 4 AVT ICDs. It is believed that the Guidant Corp. failed to inform doctors or patients for over three years that some of their defibrillators had a defect that could cause the devices to short-circuit. Less than one week later the Guidant Company issued a second safety advisory about its implantable defibrillators. Guidant told doctors to stop using five of the models because they could malfunction because of a defective switch. The latest warning applies to Guidant's Contak Renewal 3 and 4 models, Renewal RF model and the Renewal 3 and 4 AVT devices.
Recalled Models:
- Renewal 3 and 4 AVT
- Renewal RF
- Prizm 2 DR, Model 1861
- Contak Renewal, Model H135
- Contak Renewal 2, Model H155
- Prizm AVT Vitality AVT Renewal 3
- AVT Renewal 4 AVT
- Contak Renewal 3 and 4
Our lawyers can help you obtain the recovery you deserve. Call us day or night, we can help. Call us at 1-800-862-1260.
Guidant Prizm # 2 DR Defibrillator
The Guidant Prizm #2 DR Defibrillator was recently recalled as part of Guidant Corporation's overall recall of defective defibrillators. The Guidant Prizm # 2 Defibrillator was designed to treat heart patient arrhythmias, both irregular or dangerously fast heart rhythms, that originate in either the upper or lower chambers of the heart. The defect with the defibrillator causes it to short circuit and malfunction resulting in serious injury or death. The Prizm # 2 DR Defibrillator VENTAK PRIZM #2 Devices use the initial detection criteria of cardiac cycle length (rate) and duration (seconds) to assess and determine therapy response to tachyarrhythmias by zone. VENTAK PRIZM 2 devices also offer antitachycardia pacing.The failure of the Prizm 2 DR defibrillator to function properly can result in serious injury or death of the patient. The Guidant's recall of the defective defibrillators comes after the company failed to inform doctors or patients for over three years about the defect. It is believed that the Guidant Corporation knew for year that one of its defibrillators, the Ventak Prizm 2 Model 1861, implanted in an estimated 24,000 patients was defective. The defibrillator defect came to light after the sudden death in March of a 21-year-old college student with heart disease who had the Guidant defibrillator implanted in his chest, the report said. Guidant, which was acquired by Johnson & Johnson, acknowledged that Joshua Oukrop's defibrillator had short-circuited. Following the death, Guidant told its' doctors that it was aware of 25 other cases in which the defibrillator had been affected by the same flaw. Guidant executive, Dr. Smith, as saying the medical device maker had not seen a compelling reason to issue an alert to physicians because the unit's failure rate was very low and replacing the devices might pose greater patient risks.
Our lawyers can help you obtain the recovery you deserve. Call us day or night, we can help. Call us at 1-800-862-1260.
Guidant Recalls the Contak Renewal
The Guidant Corporation recalls the CONTAK RENEWAL cardiac resynchronization therapy defibrillator. The Contak Renewal defibrillator provides cardiac resynchronization therapy for the treatment of heart failure by providing electrical stimulation to the right and left ventricles to synchronize ventricular contractions. The defect causes the defibrillator to short circuit and malfunction resulting in serious injury or death. The Contak Renewal was designed to provide ventricular tachyarrhythmia therapy to treat ventricular tachycardia and ventricular fibrillation which are both associated with sudden cardiac death (SCD). Ventricular tachycardia and ventricular fibrillation can cause death if the defibrillator does not provide electrical stimulation to the heart at the right time. Guidant's recall of the defective defibrillators comes after the company failed to inform doctors or patients for over three years about the defect. It is believed that the Guidant Corporation knew that one of its defibrillators, the Ventak Prizm 2 Model 1861, implanted in an estimated 24,000 patients was defective.
Our lawyers can help you obtain the recovery you deserve. Call us day or night, we can help. Call us at 1-800-862-1260.
Guidant Recalls the Contak Renewal 3
The Guidant corporation recalled the CONTAK RENEWAL 3 cardiac resynchronization therapy defibrillator (CRT-D. The Contak Renewal defibrillator provides ventricular tachyarrhythmia therapy and cardiac resynchronization therapy (CRT) for the treatment of heart failure by providing electrical stimulation to the right and left ventricles to synchronize ventricular contractions. The defect causes the defibrillator to short circuit and malfunction resulting in serious injury or death. The Contak Renewal 3 was Guidant's best selling defibrillator model. Ventricular tachyarrhythmia therapy is used to treat ventricular tachycardia and ventricular fibrillation which are both associated with sudden cardiac death (SCD). Cardiac resynchronization therapy is for the treatment of heart failure (HF) and uses biventricular electrical stimulation to synchronize ventricular contractions. Ventricular tachycardia, ventricular fibrillation and heart failure can all cause death if the Contak Renewal 3 defibrillator does not function properly when it is critically needed.
Our lawyers can help you obtain the recovery you deserve. Call us day or night, we can help. Call us at 1-800-862-1260.